1+2 Might Be >2: SGLT Inhibition in Patients With Heart Failure or Chronic Kidney Disease

Bertram Pitt; Deepak L. Bhatt

doi:10.1016/j.jchf.2023.08.007

1+2 Might Be >2: SGLT Inhibition in Patients With Heart Failure or Chronic Kidney Disease

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	222-225
Number of pages	4
Journal	JACC: Heart Failure
Volume	12
Issue number	1
DOIs	https://doi.org/10.1016/j.jchf.2023.08.007
State	Published - Jan 2024

Keywords

SGLT inhibition
chronic kidney disease
heart failure
sotagliflozin
type 2 diabetes

Access to Document

10.1016/j.jchf.2023.08.007

Cite this

@article{1d2d50aa6a094aa782e5d207346749ad,

title = "1+2 Might Be >2: SGLT Inhibition in Patients With Heart Failure or Chronic Kidney Disease",

keywords = "SGLT inhibition, chronic kidney disease, heart failure, sotagliflozin, type 2 diabetes",

author = "Bertram Pitt and Bhatt, {Deepak L.}",

year = "2024",

month = jan,

doi = "10.1016/j.jchf.2023.08.007",

language = "English",

volume = "12",

pages = "222--225",

journal = "JACC: Heart Failure",

issn = "2213-1779",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - 1+2 Might Be >2

T2 - SGLT Inhibition in Patients With Heart Failure or Chronic Kidney Disease

AU - Pitt, Bertram

AU - Bhatt, Deepak L.

PY - 2024/1

Y1 - 2024/1

KW - SGLT inhibition

KW - chronic kidney disease

KW - heart failure

KW - sotagliflozin

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85174014542&partnerID=8YFLogxK

U2 - 10.1016/j.jchf.2023.08.007

DO - 10.1016/j.jchf.2023.08.007

M3 - Editorial

C2 - 37768249

AN - SCOPUS:85174014542

SN - 2213-1779

VL - 12

SP - 222

EP - 225

JO - JACC: Heart Failure

JF - JACC: Heart Failure

IS - 1

ER -